Daniel D Lydiatt1. 1. Department of Otolaryngology, University of Nebraska Medical Center and Methodist Cancer Center, Omaha 68198-1225, USA.
Abstract
OBJECTIVE: To analyze malpractice litigation initiated by patients with cancer of the oral cavity as a result of allegations concerning their diagnosis and treatment. STUDY DESIGN: Retrospective review. METHODS: Jury verdict reviews from 1984 to 2000 were obtained from a computerized legal database and analyzed. Reviews compile pertinent data on defendants, plaintiffs, verdict outcomes, indemnity payments, and allegations of wrongdoing and provide case summaries. Fifty cases from 21 of all 50 states were obtained. Data were entered into a spreadsheet for analysis. RESULTS: Overall, a young age (mean age, 45 y) and poor oncological outcome (47% dead) were seen. The younger age group (<47 y) had a better outcome (65% without disease), were more often misdiagnosed (19%), won awards (60%), and had higher awards (average award, $755,824) as compared with those older than 47 years of age, who had 39% without disease, 0% misdiagnosed, and 52% who won awards that were less, on average, at $495,417. Failure to diagnose the cancer was alleged, overall, in 43 of 50 cases (86%), and in general practice, dentists, and otolaryngologist in 100%, 85%, and 89%, respectively. Suits alleging a delay in diagnosis of less than 3 months were defendant verdicts in 86%, and of more than 3 months, in 40%. Failures to perform biopsy and to refer were common allegations. CONCLUSIONS: Young age of patients bringing litigation is seen in patients with oral cancer. These patients frequently have poor oncological outcomes. Risk management goals to prevent delays in diagnosis may help prevent subsequent litigation.
OBJECTIVE: To analyze malpractice litigation initiated by patients with cancer of the oral cavity as a result of allegations concerning their diagnosis and treatment. STUDY DESIGN: Retrospective review. METHODS: Jury verdict reviews from 1984 to 2000 were obtained from a computerized legal database and analyzed. Reviews compile pertinent data on defendants, plaintiffs, verdict outcomes, indemnity payments, and allegations of wrongdoing and provide case summaries. Fifty cases from 21 of all 50 states were obtained. Data were entered into a spreadsheet for analysis. RESULTS: Overall, a young age (mean age, 45 y) and poor oncological outcome (47% dead) were seen. The younger age group (<47 y) had a better outcome (65% without disease), were more often misdiagnosed (19%), won awards (60%), and had higher awards (average award, $755,824) as compared with those older than 47 years of age, who had 39% without disease, 0% misdiagnosed, and 52% who won awards that were less, on average, at $495,417. Failure to diagnose the cancer was alleged, overall, in 43 of 50 cases (86%), and in general practice, dentists, and otolaryngologist in 100%, 85%, and 89%, respectively. Suits alleging a delay in diagnosis of less than 3 months were defendant verdicts in 86%, and of more than 3 months, in 40%. Failures to perform biopsy and to refer were common allegations. CONCLUSIONS: Young age of patients bringing litigation is seen in patients with oral cancer. These patients frequently have poor oncological outcomes. Risk management goals to prevent delays in diagnosis may help prevent subsequent litigation.
Authors: Timothy J Abram; Pierre N Floriano; Nicolaos Christodoulides; Robert James; A Ross Kerr; Martin H Thornhill; Spencer W Redding; Nadarajah Vigneswaran; Paul M Speight; Julie Vick; Craig Murdoch; Christine Freeman; Anne M Hegarty; Katy D'Apice; Joan A Phelan; Patricia M Corby; Ismael Khouly; Jerry Bouquot; Nagi M Demian; Y Etan Weinstock; Stephanie Rowan; Chih-Ko Yeh; H Stan McGuff; Frank R Miller; Surabhi Gaur; Kailash Karthikeyan; Leander Taylor; Cathy Le; Michael Nguyen; Humberto Talavera; Rameez Raja; Jorge Wong; John T McDevitt Journal: Oral Oncol Date: 2016-07-20 Impact factor: 5.337
Authors: Henning Hanken; Juliane Kraatz; Ralf Smeets; Max Heiland; Alexandre Thomas Assaf; Marco Blessmann; Wolfgang Eichhorn; Till Sebastian Clauditz; Alexander Gröbe; Andreas Kolk; Madiha Rana Journal: Head Face Med Date: 2013-08-23 Impact factor: 2.151